Asset Advisors Corp’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,998
Closed -$536K 178
2016
Q1
$536K Sell
1,998
-36
-2% -$9.66K 0.12% 80
2015
Q4
$636K Sell
2,034
-1,386
-41% -$433K 0.14% 78
2015
Q3
$930K Sell
3,420
-3,844
-53% -$1.05M 0.23% 67
2015
Q2
$2.2M Buy
+7,264
New +$2.2M 0.49% 52
2015
Q1
Sell
-19,930
Closed -$4.24M 167
2014
Q4
$4.24M Hold
19,930
0.94% 40
2014
Q3
$3.55M Hold
19,930
0.81% 43
2014
Q2
$3.37M Buy
19,930
+200
+1% +$31.1K 0.77% 43
2014
Q1
$2.45M Buy
19,730
+6,675
+51% +$813K 0.58% 49
2013
Q4
$1.45M Buy
13,055
+11,705
+867% +$1.12M 0.35% 58
2013
Q3
$122K Sell
1,350
-200
-13% -$18K 0.03% 104
2013
Q2
$131K Buy
+1,550
New +$161K 0.04% 102

Other funds holding AGN

Asset Advisors Corp's AGN Position: Q2 2016 in Review

Asset Advisors Corp sold out of Allergan Inc (AGN) in Q2 2016, closing a stake of 1,998 shares — an estimated $536K sold.

Asset Advisors Corp first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $4.24M in Q4 2014. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Asset Advisors Corp reported no remaining Allergan Inc position as of Q2 2016 after selling out during the quarter.
  • Asset Advisors Corp sold 1,998 Allergan Inc shares in Q2 2016, an estimated $536K.
  • Asset Advisors Corp first reported a position in Allergan Inc in Q2 2013 and held it in 11 quarters.
  • Asset Advisors Corp's Allergan Inc position peaked at $4.24M in Q4 2014.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2016.

Based on Asset Advisors Corp's 13F filing for Q2 2016, filed 3 Aug 2016.